Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,666
Total Claims
$647K
Drug Cost
1,704
Beneficiaries
$379
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+64%
Opioid rate vs peers
75.4% vs 45.9% avg
-21%
Cost per patient vs peers
$379 vs $483 avg
+94%
Brand preference vs peers
8.0% vs 4.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
75.4%
Opioid Rate
7,288
Opioid Claims
$447K
Opioid Cost
18.0%
Long-Acting Rate
This provider's opioid prescribing rate of 75.4% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 775 claims · $311K
Generic: 8,891 claims · $336K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 191 | $124K |
| Oxycodone Hcl/Acetaminophen | 1,896 | $81K |
| Oxycodone Hcl | 1,998 | $52K |
| Oxycodone Hcl | 104 | $47K |
| Hydrocodone/Acetaminophen | 1,351 | $45K |
| Buprenorphine Hcl/Naloxone Hcl | 102 | $36K |
| Buprenorphine Hcl | 43 | $23K |
| Pregabalin | 555 | $20K |
| Buprenorphine | 40 | $18K |
| Morphine Sulfate | 794 | $17K |
| Naloxone Hcl | 159 | $13K |
| Linaclotide | 16 | $9,986 |
| Hydromorphone Hcl | 362 | $8,849 |
| Hydrocodone Bitartrate | 16 | $7,671 |
| Naloxegol Oxalate | 14 | $5,780 |
Prescribing Profile
44
Unique Drugs
26.0
Anomaly Score
Patient Profile
63
Avg Age
60%
Female
2.34
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About